Please wait





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  The figure in Item 11 is based upon 123,877,111 common shares ("Common Shares") of ADC Therapeutics SA (the "Issuer") outstanding as of October 31, 2025, as disclosed in the Issuer's quarterly report on Form 10-Q for the quarterly period ended September 30, 2025, filed with the U.S. Securities and Exchange Commission (the "Commission") on November 10, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  The figure in Item 11 is based upon 123,877,111 shares of Common Shares outstanding as of October 31, 2025, as disclosed in the Issuer's quarterly report on Form 10-Q for the quarterly period ended September 30, 2025, filed with the Commission on November 10, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  The figure in Item 11 is based upon 123,877,111 shares of Common Shares outstanding as of October 31, 2025, as disclosed in the Issuer's quarterly report on Form 10-Q for the quarterly period ended September 30, 2025, filed with the Commission on November 10, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  The figure in Item 11 is based upon 123,877,111 shares of Common Shares outstanding as of October 31, 2025, as disclosed in the Issuer's quarterly report on Form 10-Q for the quarterly period ended September 30, 2025, filed with the Commission on November 10, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  The figure in Item 11 is based upon 123,877,111 shares of Common Shares outstanding as of October 31, 2025, as disclosed in the Issuer's quarterly report on Form 10-Q for the quarterly period ended September 30, 2025, filed with the Commission on November 10, 2025.


SCHEDULE 13G



 
Prosight Management, LP
 
Signature:Prosight Partners, LLC
Name/Title:General Partner
Date:11/13/2025
 
Signature:/s/ W. Lawrence Hawkins
Name/Title:Sole Manager of the General Partner
Date:11/13/2025
 
Prosight Fund, LP
 
Signature:Prosight Management, LP
Name/Title:General Partner
Date:11/13/2025
 
Signature:Prosight Partners, LLC
Name/Title:Sole Manager of the General Partner
Date:11/13/2025
 
Signature:/s/ W. Lawrence Hawkins
Name/Title:Sole Manager of the General Partner of the General Partner
Date:11/13/2025
 
Prosight Plus Fund, LP
 
Signature:Prosight Management, LP
Name/Title:General Partner
Date:11/13/2025
 
Signature:Prosight Partners, LLC
Name/Title:General Partner of the General Partner
Date:11/13/2025
 
Signature:/s/ W. Lawrence Hawkins
Name/Title:Sole Manager of the General Partner of the General Partner
Date:11/13/2025
 
Prosight Partners, LLC
 
Signature:/s/ W. Lawrence Hawkins
Name/Title:Sole Manager
Date:11/13/2025
 
W. Lawrence Hawkins
 
Signature:/s/ W. Lawrence Hawkins
Name/Title:W. Lawrence Hawkins
Date:11/13/2025
Exhibit Information

Exhibit 99.1: Joint Filing Agreement (incorporated herein by reference to Exhibit 99.1 to the Schedule 13G filed on April 17, 2023, by the Reporting Persons with the SEC).